MD1341Z - Method for predicting the risk of vascular accidents in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction - Google Patents
Method for predicting the risk of vascular accidents in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction Download PDFInfo
- Publication number
- MD1341Z MD1341Z MDS20180121A MDS20180121A MD1341Z MD 1341 Z MD1341 Z MD 1341Z MD S20180121 A MDS20180121 A MD S20180121A MD S20180121 A MDS20180121 A MD S20180121A MD 1341 Z MD1341 Z MD 1341Z
- Authority
- MD
- Moldova
- Prior art keywords
- vascular accidents
- risk
- predicting
- patients
- heart failure
- Prior art date
Links
- 230000002792 vascular Effects 0.000 title abstract 4
- 208000004990 Cardiorenal syndrome Diseases 0.000 title 1
- 206010019280 Heart failures Diseases 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010049694 Left Ventricular Dysfunction Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000024924 glomerular filtration Effects 0.000 abstract 1
- 210000005246 left atrium Anatomy 0.000 abstract 1
Landscapes
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
The invention relates to medicine, in particular to cardiology and nephrology.Summary of the invention consists in that it is conducted the clinical and paraclinical examination, where is estimated the glomerular filtration rate using the MDRD (RFGmdrd) formula, is determined the duration of cardiovascular disease (DBCV), the stress frequency (STRESS) and the presence of vascular accidents in the anamnesis (AVC), is conducted the echocardiographic study with the assessment of the left ventricular dysfunction and the left atrium (AS) diameter, and the discriminant function (F) is calculated by the formula:F = - 11,352 + 1,820 · STRESS + 2,061 · AVC + 1,135 · RFGmdrd + 0.064 · AS + 0.035 · DBCV,in the case when F < 0 is predicted an increased risk of vascular accidents, and F < 0 - a low risk of vascular accidents.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20180121A MD1341Z (en) | 2018-12-11 | 2018-12-11 | Method for predicting the risk of vascular accidents in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20180121A MD1341Z (en) | 2018-12-11 | 2018-12-11 | Method for predicting the risk of vascular accidents in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1341Y MD1341Y (en) | 2019-06-30 |
| MD1341Z true MD1341Z (en) | 2020-01-31 |
Family
ID=67069689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20180121A MD1341Z (en) | 2018-12-11 | 2018-12-11 | Method for predicting the risk of vascular accidents in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1341Z (en) |
-
2018
- 2018-12-11 MD MDS20180121A patent/MD1341Z/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD1341Y (en) | 2019-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Savale et al. | Acute decompensated pulmonary hypertension | |
| Kanjanahattakij et al. | High right ventricular stroke work index is associated with worse kidney function in patients with heart failure with preserved ejection fraction | |
| MX2021003845A (en) | Compositions for reducing serum uric acid. | |
| Pascotto et al. | Global and regional left ventricular function in patients undergoing transcatheter closure of secundum atrial septal defect | |
| WO2014100703A2 (en) | Method for treating diastolic heart failure by inhibiting galectin-3 | |
| MD1339Z (en) | Method for predicting the risk of death in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction | |
| Fitchett et al. | Impaired cardiac function in metabolic syndrome | |
| GERDTS et al. | Organ damage and pathophysiology | |
| MD833Y (en) | Method for early prediction of the evolution of acute myocardial infarction in patients with pancreatic diabetes | |
| Li et al. | P2441 Donepezil treatment prevents the progression of chronic heart failure in spontaneously hypertensive rats with extensive myocardial infarction | |
| Caneiro et al. | P6287 Benefit of dual antiplatelet therapy overtime with prasugrel or ticagrelor in elderly patients | |
| Heidrich et al. | P2440 Chromogranin B-emerging biomarker in heart failure | |
| Alonso Salinas et al. | P6286 Role of Frailty on acute coronary syndromes in the elderly | |
| Dobrecky-Mery et al. | Renal safety in ACS patients with Galvus (Vidagliptin) treatment | |
| Katsi et al. | INFLAMMATION AND ESSENTIAL HYPERTENSION: A DIPTYCH WHICH AFFECTS QUALITY OF LIFE: PP. 15.63 | |
| Dzeshka et al. | P6515 Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction | |
| Berden | Eosinophilic myocarditis: case report | |
| Kawataki | OC02. 06: The effective fetal screening using the distance between the descending aorta and left atrial posterior wall in four chamber view for Total Anomalous Pulmonary Venous Return. | |
| Cannone et al. | Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases | |
| Strocchi et al. | QUANTIFICATION DAILY PHYSICAL ACTIVITY IN MIDDLE-AGE HYPERTENSIVE PATIENTS LIVING IN THE CITY OF BOLOGNA: PP. 15.62 | |
| Bytyci et al. | Left atrial changes in early stage of heart failure with preserved ejection fraction | |
| Imanov et al. | IT Murkamilov, IS Sabirov2, Zh. A. Murkamilova3, VV Fomin4, AI Sabirova2, KA Aitbaev5 | |
| GULATI | OD Gulati Prize | |
| Çavuşoğlu et al. | Ivabradine has no Effect on Cardiac Arrhythmias Observed During Dobutamine Infusion: A Comparative Study with β Blocker Therapy | |
| Moreira et al. | OBSTRUCTIVE SLEEP APNEA, HYPERTENSION AND THEIR INTERACTION ON ARTERIAL AND HEART REMODELING: PP. 15.61 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |